Tilak Khanal
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
47
Citations
1,687
Est. group size
~1
Recurring co-author estimate
Active years
18
Publishing since 2008
Tilak Khanal's publications span molecular and cellular biology topics including thyroid and breast cancer signaling pathways, kidney-related toxin effects on fat cells, and gene regulation in liver injury and cancer. The work draws on techniques from genomics, epigenetics, and cell biology, applied mainly to cancer progression and metabolic disease mechanisms in laboratory models. Publication topics are fairly varied, touching cancer biology, toxicology, and even some unrelated applied health science studies.
Publication output has been low and irregular over the last decade, with a small increase in output in 2025 after a gap in 2021.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells
Endocrine Related Cancer · 2025
- Comparison of Instrument-Assisted Soft Tissue Mobilisation and Myofascial Decompression (Cupping Therapy) on Sprint Speed and Flexibility in Fast Bowlers with Tight Hamstrings
Journal of Health and Allied Sciences NU · 2025
- RETRACTED: Bartlett et al. Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models. Int. J. Mol. Sci. 2018, 19, 2685
International Journal of Molecular Sciences · 2025
- Activation of the Na/K-ATPase oxidant amplification loop by uremic toxins drivesadipocyte dysfunction in vitro
Cellular and Molecular Biology · 2025
- The <i>RCAN1.4</i> Metastasis Suppressor Is Hypermethylated at Intron 1 in Thyroid Cancer
Thyroid · 2023
- Upregulation of CYP1B1 by hypoxia is mediated by ERα activation in breast cancer cells
Research Square · 2022
- OR09-2 The RCAN 1.4 Metastasis Progression Suppressor Gene is Hypermethylated at Intron 1 and Downregulated in Papillary Thyroid Cancer
Journal of the Endocrine Society · 2022
- RF11 | PSAT369 CDK7 and CDK9 Inhibition Induces RNA Polymerase II Ubiquitination and Proteasome Degradation in Thyroid Cancer Cells
Journal of the Endocrine Society · 2022
- Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications
Endocrine · 2020
- Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model
Scientific Reports · 2020
- NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries
The FASEB Journal · 2019
- Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population
PLoS ONE · 2018
- RETRACTED: Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models
International Journal of Molecular Sciences · 2018
- Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells
Food and Chemical Toxicology · 2017
- Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer
Scientific Reports · 2017
- International Journal of Molecular Sciences×2
- Scientific Reports×2
- Journal of the Endocrine Society×2
- PLoS ONE×1
- Endocrine×1
- Davinder Singh
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Emily Ho
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ajeet Kumar Verma
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Anita A. Panjwani
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Karen T. Liby
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile